 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Tiotropium and the Treatment of Chronic Obstructive Lung Disease
6 September 2005 | Volume 143 Issue 5 | Page I-20
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator. A Randomized Trial." It is in the 6 September 2005 issue of Annals of Internal Medicine (volume 143, pages 317-326). The authors are D.E. Niewoehner, K. Rice, C. Cote, D. Paulson, J.A.D. Cooper Jr., L. Korducki, C. Cassino, and S. Kesten.
What is the problem and what is known about it so far?
Chronic obstructive pulmonary disease (COPD) is a cigarette-associated abnormality of the lungs that is characterized by destruction of lung tissue and inflammation of the bronchial tubes. People with COPD usually notice chronic shortness of breath, cough, and wheezing (caused by spasm of the bronchial tubes). They may also experience abrupt worsening of their symptoms. These episodes are called exacerbations. Tiotropium is a new drug that relaxes bronchial spasm and seems to be effective in easing the chronic symptoms of COPD. Whether tiotropium is effective for preventing COPD exacerbations is less clear.
Why did the researchers do this particular study?
To see whether tiotropium could prevent exacerbations and decrease hospitalizations for COPD exacerbations.
Who was studied?
1829 patients older than 40 years of age who had moderate to severe COPD and were being cared for at Veterans Affairs Medical Centers.
How was the study done?
Researchers randomly assigned patients to receive either tiotropium or placebo (a look-alike but fake medication with no active ingredients). They collected information on symptoms and hospitalizations for COPD every month for 6 months. They then compared the number of exacerbations and hospitalizations in the 2 groups.
What did the researchers find?
Fewer patients receiving tiotropium had exacerbations than those receiving placebo. Tiotropium also reduced the number of hospitalizations for COPD exacerbations.
What are the limitations of the study?
Almost all patients were men, so the findings might not apply equally to women. The researchers compared the groups for only 6 months, and findings might differ over longer periods of time. Also, the researchers compared tiotropium with placebo, not with other drugs that are commonly used for treating COPD.
What are the implications of the study?
Tiotropium seems to be effective in reducing exacerbations and hospitalizations in patients with COPD. It is not necessarily more effective than other drugs commonly used to treat COPD.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  D. P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, S. Menjoge, M. Decramer, and the UPLIFT Study Investigators A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., October 9, 2008; 359(15): 1543 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Singh, Y. K. Loke, and C. D. Furberg Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis JAMA, September 24, 2008; 300(12): 1439 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S D Aaron Author's reply Thorax, August 1, 2008; 63(8): 750 - 750. [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Rabe, W. Timmer, A. Sagkriotis, and K. Viel Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD Chest, August 1, 2008; 134(2): 255 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Singh, J Brooks, G Hagan, A Cahn, and B J O'Connor Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD Thorax, July 1, 2008; 63(7): 592 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Todd, R. A. McIvor, S. O. Pugsley, and G. Cox Approach to chronic obstructive pulmonary disease in primary care Can Fam Physician, May 1, 2008; 54(5): 706 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Albert and P. M. A. Calverley Drugs (including oxygen) in severe COPD Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa, P. Ernst, K. L. Vandemheen, and S. D. Aaron Methodological issues in therapeutic trials of COPD Eur. Respir. J., May 1, 2008; 31(5): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. MacNee Update in Chronic Obstructive Pulmonary Disease 2007 Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oba Does Tiotropium Reduce Hospitalizations in Chronic Obstructive Pulmonary Disease? Ann Intern Med, April 15, 2008; 148(8): 626 - 626. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Braganza, R. Chaudhuri, and N. C. Thomson Review: Treating patients with respiratory disease who smoke Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Greenland, S. Lanes, and M. Jara Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation Clinical Trials, February 1, 2008; 5(1): 5 - 13. [Abstract] [PDF]
|
|
|
|
|
|
S D Aaron, D Fergusson, G B Marks, S Suissa, K L Vandemheen, S Doucette, F Maltais, J F Bourbeau, R S Goldstein, M Balter, et al. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials Thorax, February 1, 2008; 63(2): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Welte Acute Exacerbation of Chronic Obstructive Pulmonary Disease: More a Functional than an Inflammatory Problem? Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 130 - 131. [Full Text] [PDF]
|
|
|
|
|
|
G. R. Washko, V. S. Fan, S. D. Ramsey, Z. Mohsenifar, F. Martinez, B. J. Make, F. C. Sciurba, G. J. Criner, O. Minai, M. M. DeCamp, et al. The Effect of Lung Volume Reduction Surgery on Chronic Obstructive Pulmonary Disease Exacerbations Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 164 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vijayasaratha and R. A. Stockley Reported and Unreported Exacerbations of COPD: Analysis by Diary Cards Chest, January 1, 2008; 133(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wedzicha, P. M. A. Calverley, T. A. Seemungal, G. Hagan, Z. Ansari, R. A. Stockley, and for the INSPIRE Investigators The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Rennard and T. Higenbottam Exacerbation-Free COPD: A Goal Too Far? Proceedings of the ATS, December 1, 2007; 4(8): 583 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Qaseem, V. Snow, P. Shekelle, K. Sherif, T. J. Wilt, S. Weinberger, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med, November 6, 2007; 147(9): 633 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wilt, D. Niewoehner, R. MacDonald, and R. L. Kane Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline Ann Intern Med, November 6, 2007; 147(9): 639 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kesten, M. Plautz, C. A. Piquette, M. P. Habib, and D. E. Niewoehner Premature discontinuation of patients: a potential bias in COPD clinical trials Eur. Respir. J., November 1, 2007; 30(5): 898 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Hanania and J. F. Donohue Pharmacologic Interventions in Chronic Obstructive Pulmonary Disease: Bronchodilators Proceedings of the ATS, October 1, 2007; 4(7): 526 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Rabe, S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 532 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Powrie, T. M. A. Wilkinson, G. C. Donaldson, P. Jones, K. Scrine, K. Viel, S. Kesten, and J. A. Wedzicha Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Eur. Respir. J., September 1, 2007; 30(3): 472 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Naylor, D. Bakstad, M. Biffen, B. Thong, P. Calverley, S. Scott, C. A. Hart, R. J. Moots, and S. W. Edwards Haemophilus influenzae Induces Neutrophil Necrosis: A Role in Chronic Obstructive Pulmonary Disease? Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Criner Optimal Treatment of Chronic Obstructive Pulmonary Disease: The Search for the Magic Combination of Inhaled Bronchodilators and Corticosteroids Ann Intern Med, April 17, 2007; 146(8): 606 - 608. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Aaron, K. L. Vandemheen, D. Fergusson, F. Maltais, J. Bourbeau, R. Goldstein, M. Balter, D. O'Donnell, A. McIvor, S. Sharma, et al. Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease: A Randomized Trial Ann Intern Med, April 17, 2007; 146(8): 545 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Gelb, C. F. Taylor, P. A. McClean, C. M. Shinar, M. T. Rodrigues, C. A. Gutierrez, K. R. Chapman, and N. Zamel Tiotropium and Simplified Detection of Dynamic Hyperinflation Chest, March 1, 2007; 131(3): 690 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J R Hurst and J A Wedzicha What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines Thorax, March 1, 2007; 62(3): 198 - 199. [Full Text] [PDF]
|
|
|
|
|
|
P. Kardos, M. Wencker, T. Glaab, and C. Vogelmeier Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Niewoehner, Y. Lokhnygina, K. Rice, W. G. Kuschner, A. Sharafkhaneh, G. A. Sarosi, P. Krumpe, K. Pieper, and S. Kesten Risk Indexes for Exacerbations and Hospitalizations Due to COPD Chest, January 1, 2007; 131(1): 20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Brusasco Reducing cholinergic constriction: the major reversible mechanism in COPD Eur. Respir. Rev., December 1, 2006; 15(99): 32 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. O'Donnell Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance Eur. Respir. Rev., December 1, 2006; 15(99): 37 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rodriguez-Roisin Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Eur. Respir. Rev., December 1, 2006; 15(99): 47 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Decramer Tiotropium as essential maintenance therapy in COPD Eur. Respir. Rev., December 1, 2006; 15(99): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Heffner Update in pulmonary medicine. Ann Intern Med, November 21, 2006; 145(10): 765 - 773. [Full Text] [PDF]
|
|
|
|
|
|
R G Barr, J Bourbeau, C A Camargo, and F S F Ram Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis Thorax, October 1, 2006; 61(10): 854 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Knight and S. D. Fihn Update in General Internal Medicine Ann Intern Med, July 4, 2006; 145(1): 52 - 61. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe Update in chronic obstructive pulmonary disease 2005. Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
S Scott, P Walker, and P M A Calverley COPD exacerbations {middle dot} 4: Prevention Thorax, May 1, 2006; 61(5): 440 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dusser, M-L. Bravo, P. Iacono, and on behalf the MISTRAL study group The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur. Respir. J., March 1, 2006; 27(3): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. O'Connor Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium Ann Intern Med, January 17, 2006; 144(2): 148 - 148. [Full Text] [PDF]
|
|
|
|
|
|
C. B. Good and L. Longo Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium Ann Intern Med, January 17, 2006; 144(2): 147 - 147. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Turino Therapeutic Gains of Prolonged Bronchial Dilatation in Chronic Obstructive Pulmonary Disease Ann Intern Med, September 6, 2005; 143(5): 386 - 387. [Full Text] [PDF]
|
|
Read all Rapid Responses
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
